Objectives  Oh, the age-old debate of sniffing gas versus getting a drip in the quest to keep patients blissfully unaware while their skulls are being tinkered with. This time, we’re pitting the mighty desflurane, known for its party trick of dilating brain vessels, against the stoic propofol in a battle royale featuring patients with the enigmatic moyamoya disease. The goal? To see who wakes up with their neurons firing on all cylinders.

Materials and Methods  After getting a thumbs-up from the ethics squad, we threw patients with moyamoya disease into a gladiatorial arena (figuratively speaking) to see whether desflurane or propofol would lead them to victory—or at least a decent neurological outcome post-brain plumbing. We measured their brainy responses with fancy scores at discharge and a month later, while also keeping an eye on how chill their brains were during the show.

Statistical Analysis  We crunched numbers with all the usual statistical hocus-pocus to see if there was any method to the madness. Spoiler alert: we used t-tests, Mann-Whitney U tests, and chi-squared tests to make sure we weren’t just making educated guesses.

Results  Drumroll, please… Out of the 17 brave souls, 10 huffed desflurane and 7 got the propofol IV drip. Turns out, their post-op brain game was pretty much the same, statistically speaking. But, oh boy, the desflurane group needed more “rescue measures” (whatever that entails) to keep their brains from throwing a fit during surgery.

Conclusion  In the end, it’s a tie on the neurological scoreboard post-surgery, but if you want a smoother sailing during the brainy voyage, propofol might just be your captain. So, pick your potion, but remember, it’s all the same once the dust settles—or in this case, once the brain relaxes.